As many as 2 million patients worldwide likely have been exposed to a class of generic blood-pressure drugs containing probable human carcinogens, the FDA estimates in a report from The Wall Street Journal.
Pharmacy
The Pharmaceutical Research and Manufacturers of America, the industry's main trade group, is considering a proposal that will cap drug price increases for Medicare, according to a report from BioCentury.
CVS Health, which operates one of the largest pharmacy benefit manager units in the U.S., has added migraine drugs from Teva Pharmaceuticals and Eli Lilly to its formulary, while excluding coverage of a rival treatment from Amgen, Reuters reports.
Walgreens will acquire about half of Shopko's pharmacies, according to The Wall Street Journal.
New shortages of blood pressure drugs in the U.S. are likely after a string of recent recalls linked to the discovery of a probable human carcinogen in the medications, the FDA warned Jan. 25.
Advertisement
The latest round of pricing changes for generic medications could save Medicaid $126 million annually, according to data analyzed by 46brooklyn research.
A key study failed to show Eli Lilly's cancer drug Lartruvo prolonged lives. Now, the FDA is warning that the medication shouldn't be used in new patients and those already taking it should ask their physicians if they should continue,…
Walgreens shareholders preliminarily approved a plan requiring the company to explain its strategy for monitoring and managing the risks associated with the U.S. opioid crisis, according to CNBC.
AbbVie reported a net loss of $1.83 billion in the fourth quarter of 2018, down from the company's net income of $52 million in the same period last year, Investor Place reports.
Civica Rx, the nonprofit generic drug company formed by a group of hospital systems, expects to provide about 20 products this year to alleviate shortages, according to Reuters.